279 results found
In the past week, India conducted approximately 8.9 million inoculations, with an average of almost 1.27 million doses a day.
This “niche diplomacy” is expected to be one of the key guiding principles of Emirati foreign policy in 2021.
As many countries in the Indo-Pacific struggle to meet their vaccination targets, India could spearhead a vaccine initiative in close collaboration wi
Wealthy nations have turned towards subsiding their own pharmaceutical companies and locking in vaccine supplies for their population.
The impact of the pandemic has been so pervasive that every prominent political and social issue facing the UK has become enmeshed with it.
After the initial lukewarm response, India’s daily inoculations observed a much-needed boost.
Novavax started off as one of the strongest contenders, promising 2 billion doses in 2021, despite failing to bring to market a single vaccine candidate in its 34-year-old his-tory.
Vaccine equity in Massachusetts has been called the “best of the worst”; although doing better than other states in terms of equitable distributio
The race to secure COVID-19 vaccines has laid bare the inherent inequalities in access to global healthcare, which adversely affects developing popula
The case of Australia and Pacific Island countries is instructive on what can be done — and what still needs to be done.
India has achieved better Covid-19 vaccine coverage than most other countries in its income class, aided mainly by domestic production capacity and the government’s decision to offer the vaccines to the adult population for free. There are stark sub-national differences, however, in the pace and coverage of the vaccine rollout. This special report tells the story of the district of Raigarh in Chhattisgarh—one of the low-income, Empowered Acti
Peaceful international partnerships in crucial sectors, like healthcare, continue to inspire India’s global vision.
Multiple molecular checks ensure that the COVID-19 vaccine does not affect human DNA, thus, the chances of this occurring are highly improbable
The COVID-19 pandemic has mutated into a global political economy crisis, with new fault lines emerging along market shares and intellectual property
As seen in the Chinese case, the vaccine manufacturers have not only lost trust domestically but also internationally.
Throughout this ordeal, one must remain modest.
The race to develop a COVID-19 vaccine is gaining ground in many parts of the world. This brief examines the challenges that India must hurdle to successfully manufacture and distribute a vaccine. It argues for a fair and equitable distribution of vaccine with an aim to save the maximum number of lives. It suggests a multi-parameter model based on age, co-morbidity, income and profession to justify one’s claim for vaccine. The imperative is to
The remedy to overcome India’s healthcare afflictions calls for the amalgamation of data, technology and collaboration.
The EU’s push for multilateralism on developing a vaccine against COVID-19 comes amidst fraying international relations
There is an urgent need to strengthen routine immunisation to prevent the risk of vaccine-preventable disease in children, according to Lancet.
India still has about one week left before deciding the fate of its nationwide lockdown. Therefore, if there are lessons to be learnt from the countri
India has shown commendable progress in eliminating vaccine-preventable diseases through robust immunisation programmes
Enforcing a sense of discipline among 170 million people, sharply divided on sectarian and linguistic lines, is never an easy task as it requires volu
The world’s pharmacy is looking to inoculations to build friendly ties around the world—and compete with China.
As New Delhi and Taipei draw closer together, the map of the Asia-Pacific could change for good.
